In 1984, Benita Fitzgerald Mosley won gold at the 1984 Olympics. Now, the former Olympian is the CEO of Laureus USA and is on a mission to bring sports to under-served kids across the U.S.
Laureus USA works in cities to bring free sports programs to kids. Mosley explains that the programs also include mentoring, college counseling, and other development tools.
Mosley says one of the greatest obstacles preventing kids from getting into sports programs in the cost barrier. She also acknowledges the performance barrier due to the professionalism of kid sports. With college scholarships and other opportunities on the line, elite and expensive training programs are keeping some kids out.
When asked about what it is like to win a gold medal at the Olympics, Mosley compared it to being a 5 year-old on Christmas morning. She said she still cries whenever the national anthem plays for a fellow American athlete.
Chipotle filed a lawsuit in California federal court against Sweetgreen over the salad chain's chicken burrito bowl, claiming infringement for using the word "chipotle" in the name.
The head of UBS has voiced confidence that the Swiss bank will succeed in a government-engineered takeover of hobbled rival Credit Suisse.
Jeep unveiled its 2024 Wrangler SUV, with more capabilities and updated technology.
Major crypto tokens, including Bitcoin, are trading higher.
Bed Bath & Beyond struck a deal with an investment management firm to get more product on the shelves in an effort to avoid bankruptcy.
Google revealed details of its new artificial intelligence supercomputer on Wednesday.
Demand for mortgages was down last week, even though rates inched lower for potential homebuyers.
Walmart told shareholders Wednesday that inflation is impacting the business. Now it is looking to add automation to offset hiring.
Bob Lee, a technology executive who created Cash App and was currently chief product officer of MobileCoin, has been fatally stabbed in San Francisco.
The Food and Drug Administration has announced that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow safety protocols.
